Medium urgency

MO HB 2: House Bill 2

Detected August 9, 2026 · in Healthcare AI Regulation (FDA / ONC)

House Bill 2 introduces new regulations for AI in healthcare, impacting compliance for health systems and medical device companies.

Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health systems, medical device companies, health tech startups, and digital health compliance teams. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

New regulatory framework for AI applications in healthcare, including requirements for bias audits and clinical decision support systems.

Who it affects

Health systems, medical device companies, health tech startups, and digital health compliance teams.

What you must do

Review and update compliance protocols to align with the new AI regulations outlined in House Bill 2.

Deadline

Not specified.

Source: https://documents.house.mo.gov/xml/261-HB2.xml

Never miss a change like this again

Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Healthcare AI Regulation (FDA / ONC)